Factors influencing cold ischaemia time in deceased donor kidney transplants
Item Status
Embargo End Date
Date
Authors
Abstract
Kidney transplant remains the optimal treatment for majority of patients with end
stage renal failure. The major challenge facing the transplant community is the
shortage of organs for donation as demand outstrips supply. This has led to a
significant change in practice over the last decade with an increasing use of kidneys
from deceased donors following circulatory death (DCD) and extended criteria
donors (ECD) that are more susceptible to ischaemic injury.
A period of cold ischemia time (CIT) is an inevitable consequence of organ retrieval
and transplantation in the process of deceased organ donation. It is well established
that longer CIT is associated with poorer outcomes following kidney transplantation.
It is also one of the few potentially modifiable risk factors. It is, therefore, crucial to
identify and address the factors that adversely affect CIT to enable optimal utilisation
of available kidneys.
The study investigated multiple factors affecting CIT, involving all aspects of kidney
journey from retrieval to transplantation to identify areas for improvement.
The aims of the study are:
• To undertake comprehensive review of logistical factors in transplant
centres in the United Kingdom (UK) and, their impact on CIT in deceased
donor kidney transplants
• To determine whether there are specific areas to focus efforts on to
reduce CIT
• To put forward proposals about how to reduce CIT across the UK
This is a prospective, longitudinal study over 14 months examining logistical
pathway of deceased donor kidney transplants in the UK that includes kidney
allocation, retrieval, transport, histocompatibility testing and preparation of
recipients for transplantation.
Four sets of questionnaires were developed and utilised to encapsulate critical events
along the kidney timeline with additional data input from the National Health Service
Blood and Transplant (NHSBT).
Results identified a number of factors that affected CIT, the most important of which
was adoption of a virtual crossmatch (vXM) policy where appropriate. CIT was also
reduced significantly if pre-transplant crossmatch (pXM) was performed with donor
pre-retrieval peripheral blood rather than donor tissues. Significant reduction also
resulted from use of stored recipient blood for pXM rather than a current sample.
Other factors that led to increase in CIT in the vXM group were travel times,
recipients requiring haemodialysis immediately before transplantation and kidney reallocation.
This study identifies specific factors that can be addressed to potentially minimise
CIT and improve outcomes in deceased donor kidney transplants in the UK.
This item appears in the following Collection(s)

